roche免疫产品原料简介

免疫产品简介pictureplaceholder抗体销量最好的抗体：CKMB、DD、Ferr、Insulin、E2。Roche单抗为冻干品，建议用0.9%的生理盐水溶解，溶解浓度为10mg/ml。溶解液的储存条件：•1周(+2to+8°C),•12周(-25to-15°C).请避免反复冻融。抗体肿瘤：项目抗体批号备注CEAMABCEATU2IgGMABCEAM-TU3IgG1135371310310777498103鼠源单抗冻干AFPMABAFPM-LJ738IgGMABAFPM-TU11IgG1149210110311492080103鼠源单抗冻干FerrMABFerrM-3.170IgGMABFerrM-4.184IgG1154708910311547119103鼠源单抗冻干抗体内分泌：项目抗体批号备注LHMABLHM-11412IgGMABLHM-2.406IgG1154792510311547038103鼠源单抗冻干FSHMABFSHM-1.303IgGMABFSHM-W3IgG1149354010311493531103鼠源单抗冻干HCGMABHCGM-INN22IgGMABHCGM-INN2IgG1181256410303116263103鼠源单抗冻干PRLMABPRLM-C4E4IgGMABPRLM-H12G10IgG1145870110311027689103鼠源单抗冻干E2PAKE2KIgG05344255103兔源多抗液体抗体甲功：项目抗体批号备注TSHMABTSHM-1.20IgGMABTSHM-A8IgG1076777810311367978103鼠源单抗冻干T3PABT3SIgG10907332103羊源多抗冻干T4PABT4SIgG10767794103羊源多抗冻干抗体其他：项目抗体批号备注InsulinMABINSULINM-ST3IgGMABINSULINM-BM1IgG1220875010312208725103鼠源单抗冻干CK-MBMABCK-MBM-7.4.5IgGMABCK-MBM-6.12.47IgG1171981510311719823103鼠源单抗冻干D-DimerMABDDM-1.2.57IgGMABDDM-2.1.16IgG1215690310312045206103鼠源单抗冻干IgEMABIGEM-323IgGMABIGEM-7H8IgG1154339310311988204103鼠源单抗冻干CRPPABCRPSIgG11888714103羊源多抗液体酶和底物ALP底物项目抗体批号备注ALPAlkalinePhosphatase,EIAGrade10556602103液体酶活≥3000u/mgALPAlkalinePhosphatase,recombinant,highlyactive03137031103液体，酶活≥7000u/mg糖含量20-30%ALPAlkalinePhosphatase,recombinant,highlyactive,carbohydratereduce03535452103液体，酶活≥7000u/mg近天然，糖含量5-10%项目抗体批号备注pNPP4-NitrophenylPhosphate10004847103结晶粉末BCIP5-Bromo-4-chloro-3-indolyl-phosphate10760978103结晶粉末酶和底物POD底物项目抗体批号备注PODPeroxidase(POD),EIAGrade10815462103冻干酶活≥225u/mgPODPeroxidase(POD),GradeI10121606103冻干酶活≥250u/mgPODPeroxidase(POD),GradeII11378783103冻干酶活≥200u/mgPolyPODPolyPOD,EIAGrade11578545103冻干酶活≥600u/mg项目抗体批号备注TMB3,3',5,5'-Tetramethylbenzidine10203700103结晶粉末放大系统名称英文名称批号备注链霉亲和素Streptavidin,recombinant11520679103冻干生物素D-Biotin-N-hydroxysuccinimideester10734250103白色干粉，短链生物素D-Biotinoyl-ε-aminocaproicacid-N-hydroxysuccinimideester11003933103白色干粉，长链链霉素包被磁珠StreptavidinMagneticParticles11636502103悬浊液磁珠直径2um左右裸珠干扰消除蛋白非特异性干扰非特异性干扰消除蛋白BovineIgGPAB-B-IgG(DE)Cat.No.11293621•InterferencereductioninassaysystemworkingwithpolyclonalbovineIgGthroughblockingofe.g.antibodysolidphaseinterference•Basicinterferenceelimination.Specials:•IgGfractionfrombovineplasma,purifiedbyDEchromatographywith5%aggregatedIgGBSAVCat.No.10738328•Saturationofunoccupiedbindingsitesonthesolidphase•Basicinterferenceelimination.Specials:•ContainsnodetectableIgGsSheepIgGPAB-S-IgG(DE)Cat.No.10717606•InterferencereductioninassaysystemworkingwithpolyclonalsheepIgGthroughblockingofe.g.antibodysolidphaseinterference•Basicinterferenceelimination.RabbitIgGPAB-K-IgG(DE)Cat.No.10912280•InterferencereductioninassaysystemworkingwithpolyclonalrabbitIgGthroughblockingofe.g.antibodysolidphaseinterference•Basicinterferenceelimination.非特异性干扰消除蛋白BPLAI+IVBovinePlasmaAlbuminCat.Nos.1172653611726544´03535240Avoidanceofnon-specificadsorptionorantibodyinteractionsformorecomplexapplicationswithhigherdemandsonsensitivity.Specials:HighpuritypluspH4.5treatmentTypeI:purityHPLC95%,lowcontentofsteroids,lipidsandhaptensTypeIV:purityHPLC95%,TypeIVNEW!:purityHPLC95%,Protease-free!2moreproductionstepscomparedtooldversion.PolyBSAI+IICat.Nos.11866737+11816438Duetotheirownpolyvalencetheyshowoptimalprotectionagainstpolyvalentinterference(e.g.ininfectiousdiseaseassays).Thenegativechargealsoavoidshydrophobicinteractions.Specials:Veryefficientbackgroundsignalreduction.TypeI-acetylated;diameter30nmTypeII–succinylated;diameter40nmItisrecommendedtocombineamono-andapolyvalentreagent!ThetotalamountofnonspecificIEPisrecommendedtobeat2-5%.特异性干扰-MAK33家族单体IEPsNote:Theuseofaframework-specificIEPiscoveredbyRochepatent.MAK33IgG(lyo)Cat.No1200941-monoclonalIgG1antibodywithdefinedspecificity-fortestformulationsworkingwithintactIgG1-mainlyforeliminationofmonomericandspecificinterferenceIEP-'Framework’Cat.No.03369846-foreliminationofmonomericandhighlyspecificInterferenceagainsttheframeworkregions-causedbyhighlyspecificandmostlyMab-therapy-inducedHAMAS-developedbycomparingtheaminoacid-sequencesofdifferentassayantibodies-useidenticalimmunoreactiveaminoacidsequencesintheframeworkregionsoftheinterferenceeliminatingreagentasinthetestantibodies.-recommendedfortumormarker,thyroidandcardiacassays.特异性干扰-MAK33家族多聚体IEPsNote:TheuseofpolymerizedIEPsiscoveredbyRochepatent.MAK33-IgG1/IgG1Poly(liquid)Cat.No1939661•polymerizedversionofMAK33(DSSlinkerchemistry)fortestformulationsworkingwithintactIgG1•higherefficiencyconcerningHAMAinterferencetype1(spontaneousHAMAs)•mainlyforeliminationofpolymericandmoreunspecificinterference.MAK33-IgG1/Fab1Poly(lyo)Cat.No1368338•recommendedfortestsystemsworkingwithFabconjugates•comparablecharacteristicsasthea.m.MAK33-IgG/IgG1poly•inadditionitcoversFabNeo-epitopes•mainlyforeliminationofpolymericandmoreunspecificinterference.PolyMAKIgG2b/Fab2a(lyo)Cat.No1355830•recommendedfortestsystemsworkingwithIgG2aand/or2b•mainlyforeliminationofpolymericandmoreunspecificinterferenceMAK33家族选择推荐AssayIEPIgG1-IgG1assay:MAK33(60µg/ml)MAK